AstraZeneca waiting for FDA to greenlight restart of US drug trial
AstraZeneca says it's still waiting on federal approval to resume the U.S. clinical trial of its COVID-19 vaccine candidate nearly three weeks after the study was halted over safety concerns.
0 Comments